FDA Breakthrough Device using Optical Spectroscopy was Found to Significantly Increase Physicians’ Detection of Skin Cancer

2 years ago

MIAMI--(BUSINESS WIRE)--DermaSensor Inc., the pioneer of the first point-and-click skin cancer detection device for primary care physicians, announces the publication…

Metrodora Institute Appoints Dr. Brent P. Goodman, MD, as Chief Medical Officer

2 years ago

Metrodora Institute Appoints Dr. Brent P. Goodman, MD, as Chief Medical Officer to Propel Innovations in Complex Multisystem Disorder CareSALT…

BioHarvest Sciences Announces Major Product Launch of VINIA-Based Functional Coffees

2 years ago

VINIA Superfood Coffee will be a unique disruptor in the $6B US coffee pod marketFirst of three Major "VINIA Inside"…

Justera Introduces K-Beauty Online Store

2 years ago

Toronto, Ontario--(Newsfile Corp. - December 13, 2023) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) ("Justera" or the "Company")…

Metrodora Institute Appoints Dr. Brent P. Goodman, MD, as Chief Medical Officer

2 years ago

Metrodora Institute Appoints Dr. Brent P. Goodman, MD, as Chief Medical Officer to Propel Innovations in Complex Multisystem Disorder CareSALT…

Lynx.MD and Baptist Health Innovations Collaborate to Advance Medical Research and Development

2 years ago

Initiative enhances Baptist Health South Florida's efforts in medical innovation for advanced research and collaborative development.PALO ALTO, CA / ACCESSWIRE…

Halberd Corporation Signs Multi-Faceted Agreement with CrodenHealth.com

2 years ago

Peter Croden, CrodenHealth Chairman, previously executive with Pharmacia & Upjohn (Pfizer), Upjohn Canada, Upjohn Global Animal Health, NephRx, and Parnell…

SELLAS to Host Corporate Update Webinar on January 3, 2024 at 8:30 am ET

2 years ago

NEW YORK, Dec. 13, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a…

Protagonist Earns $10 Million Payment for Achievement of Clinical Milestone in Phase 2b ANTHEM-UC Study of JNJ-2113 in Adults with Moderately to Severely Active Ulcerative Colitis

2 years ago

NEWARK, CA / ACCESSWIRE / December 13, 2023 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced it has…

Research for the Treatment of a ‘Black Sheep’ Cancer Moves to Human Clinical Trials

2 years ago

With $3.5 million in funding from the GI Research Foundation, a team at the MD Anderson Cancer Center explores a…